Francesca Ristalli
Overview
Explore the profile of Francesca Ristalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Muro F, Crociani M, Nardi G, Ciardetti N, Biagiotti L, Bigi E, et al.
Catheter Cardiovasc Interv
. 2024 Dec;
PMID: 39727064
Background: Lipoprotein(a) [Lp(a)] is associated with increased cardiovascular risk, but its influence on plaque characteristics at optical coherence tomography (OCT) evaluation is not fully understood. Aims: This study seeks to...
2.
Maiani S, Nardi G, Ristalli F, Di Mario C, Meucci F
Eur Heart J Case Rep
. 2024 Jan;
8(1):ytad592.
PMID: 38188195
Background: Patients with atrial fibrillation (AF) have a five-fold increase in stroke events, and ∼90% of the thrombi develop in the left atrial appendage (LAA). Left atrial appendage occlusion (LAAO)...
3.
Meucci F, Rapillo C, Stolcova M, Scrima G, Nardi G, Nistri R, et al.
Neurol Sci
. 2023 Aug;
45(2):671-678.
PMID: 37624543
Background: The right comprehension of ischemic stroke pathogenesis guarantees the best prevention therapy. The term "patent foramen ovale (PFO) related stroke" has been proposed for those events where PFO is...
4.
Ciardetti N, Ristalli F, Nardi G, Di Mario C
Eur Heart J Case Rep
. 2022 Jan;
5(12):ytab514.
PMID: 34988363
[This corrects the article DOI: 10.1093/ehjcr/ytab448.].
5.
Ciardetti N, Ristalli F, Nardi G, Di Mario C
Eur Heart J Case Rep
. 2021 Dec;
5(11):ytab448.
PMID: 34917883
Background: Intravascular lithotripsy is safe and effective for the treatment of coronary artery calcifications. Its bail-out use in acute coronary syndrome and for underexpanded stents, although currently off-label, could be...
6.
Nardi G, De Backer O, Saia F, Sondergaard L, Ristalli F, Meucci F, et al.
EuroIntervention
. 2021 Nov;
17(17):e1397-e1406.
PMID: 34734559
Background: The presence of severe calcific atherosclerosis at the iliofemoral axis may preclude transcatheter aortic valve implantation (TAVI) by the transfemoral (TF) approach. Intravascular lithotripsy (IVL) is a novel technology...
7.
Ciardetti N, Ciatti F, Nardi G, Di Muro F, Demola P, Sottili E, et al.
Medicina (Kaunas)
. 2021 Aug;
57(7).
PMID: 34356992
Transcatheter aortic valve implantation (TAVI) has become the leading technique for aortic valve replacement in symptomatic patients with severe aortic stenosis with conventional surgical aortic valve replacement (SAVR) now limited...
8.
Stolcova M, Meucci F, Moretti C, Chiriatti N, Marcelli C, Mattesini A, et al.
Intern Emerg Med
. 2021 Mar;
16(7):1873-1882.
PMID: 33770370
A little is known about long-term hemodynamic performance of the transcatheter heart valves (THVs). The aim of the present study was to assess hemodynamic outcome, structural valve deterioration (SVD) and...
9.
Stolcova M, Ciatti F, Cardaioli F, Demola P, Fovino L, Fabris T, et al.
G Ital Cardiol (Rome)
. 2020 Dec;
21(11 Suppl 1):35S-44S.
PMID: 33295333
Transcatheter aortic valve implantation (TAVI) has been a revolution in the treatment of severe aortic stenosis evolving to a high procedural success rate and low rate of complications. Embolization of...
10.
Romano S, Ristalli F, Giglioli C, Meucci F, Stolcova M, Baldereschi G, et al.
Am J Cardiovasc Dis
. 2020 Nov;
10(4):340-349.
PMID: 33224581
Background: In spite of the increased use of Trans-catheter Aortic Valve Implantation (TAVI) due to the better patient selection, well-trained operators and improved technology, the choice of the best anesthesia...